ATE352313T1 - Pharmazeutische zusammensetzung - Google Patents

Pharmazeutische zusammensetzung

Info

Publication number
ATE352313T1
ATE352313T1 AT01927508T AT01927508T ATE352313T1 AT E352313 T1 ATE352313 T1 AT E352313T1 AT 01927508 T AT01927508 T AT 01927508T AT 01927508 T AT01927508 T AT 01927508T AT E352313 T1 ATE352313 T1 AT E352313T1
Authority
AT
Austria
Prior art keywords
pharmaceutical composition
present
cream
gel
vasculophatic
Prior art date
Application number
AT01927508T
Other languages
English (en)
Inventor
Santana Cristiano Albe Ribeiro
Original Assignee
Santana Cristiano Albe Ribeiro
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Santana Cristiano Albe Ribeiro filed Critical Santana Cristiano Albe Ribeiro
Application granted granted Critical
Publication of ATE352313T1 publication Critical patent/ATE352313T1/de

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/43—Enzymes; Proenzymes; Derivatives thereof
    • A61K38/46—Hydrolases (3)
    • A61K38/48—Hydrolases (3) acting on peptide bonds (3.4)
    • A61K38/4873—Cysteine endopeptidases (3.4.22), e.g. stem bromelain, papain, ficin, cathepsin H
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K31/35—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom
    • A61K31/352—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom condensed with carbocyclic rings, e.g. methantheline 
    • A61K31/353—3,4-Dihydrobenzopyrans, e.g. chroman, catechin
    • A61K31/355—Tocopherols, e.g. vitamin E
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/43—Enzymes; Proenzymes; Derivatives thereof
    • A61K38/46—Hydrolases (3)
    • A61K38/47—Hydrolases (3) acting on glycosyl compounds (3.2), e.g. cellulases, lactases
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0014—Skin, i.e. galenical aspects of topical compositions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/04—Drugs for skeletal disorders for non-specific disorders of the connective tissue
AT01927508T 2000-05-04 2001-05-03 Pharmazeutische zusammensetzung ATE352313T1 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
BR0006719-9A BR0006719A (pt) 2000-05-04 2000-05-04 Composição em forma de creme, gel e creme gel aplicada na terapêutica da doença de peyronie, de colagenoses e patologias fibróticas à base de vitamina-e, papaìna 2% e hialuronidase

Publications (1)

Publication Number Publication Date
ATE352313T1 true ATE352313T1 (de) 2007-02-15

Family

ID=36287935

Family Applications (1)

Application Number Title Priority Date Filing Date
AT01927508T ATE352313T1 (de) 2000-05-04 2001-05-03 Pharmazeutische zusammensetzung

Country Status (11)

Country Link
US (1) US20030161821A1 (de)
EP (1) EP1284750B1 (de)
AT (1) ATE352313T1 (de)
AU (1) AU5453701A (de)
BR (1) BR0006719A (de)
CA (1) CA2407824A1 (de)
DE (1) DE60126271T2 (de)
ES (1) ES2280363T3 (de)
MX (1) MXPA02010805A (de)
PT (1) PT1284750E (de)
WO (1) WO2001082956A1 (de)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7295509B2 (en) 2000-09-13 2007-11-13 Qualcomm, Incorporated Signaling method in an OFDM multiple access system
US9137822B2 (en) 2004-07-21 2015-09-15 Qualcomm Incorporated Efficient signaling over access channel
US9408220B2 (en) 2005-04-19 2016-08-02 Qualcomm Incorporated Channel quality reporting for adaptive sectorization
US9036538B2 (en) 2005-04-19 2015-05-19 Qualcomm Incorporated Frequency hopping design for single carrier FDMA systems
US8879511B2 (en) 2005-10-27 2014-11-04 Qualcomm Incorporated Assignment acknowledgement for a wireless communication system
US8565194B2 (en) 2005-10-27 2013-10-22 Qualcomm Incorporated Puncturing signaling channel for a wireless communication system
US8885628B2 (en) 2005-08-08 2014-11-11 Qualcomm Incorporated Code division multiplexing in a single-carrier frequency division multiple access system
US8045512B2 (en) 2005-10-27 2011-10-25 Qualcomm Incorporated Scalable frequency band operation in wireless communication systems
US8582548B2 (en) 2005-11-18 2013-11-12 Qualcomm Incorporated Frequency division multiple access schemes for wireless communication
US8465413B2 (en) 2010-11-25 2013-06-18 Coloplast A/S Method of treating Peyronie's disease

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4678668A (en) * 1985-10-28 1987-07-07 Md Associates Method of reducing soft tissue swelling and pain
US5314807A (en) * 1991-03-29 1994-05-24 Nippon Gohsei Kagaku Kogyo Kabushiki Kaisha Method for producing an angiotensin converting enzyme inhibitor-containing composition
NL9201842A (nl) * 1992-10-23 1994-05-16 Teng Hian Khoe Toepassing van een papaine bevattend voedingssupplement voor therapeutische behandeling van AIDS aandoeningen.
US5516517A (en) * 1994-05-02 1996-05-14 Exfoliation Cleansing Hydration Oxygenation Corporation Method for nutritional oxygenation of the skin
US5543149A (en) * 1995-03-01 1996-08-06 Rubin; Stan M. Treatment for insect bites
US5670142A (en) * 1996-07-08 1997-09-23 Donald Neudecker Treatment for itch of chicken pox
BR9801985B1 (pt) * 1998-04-30 2011-12-27 composiÇço farmacÊutica de uso tàpico e respectivo processo de obtenÇço.
US6031005A (en) * 1998-08-03 2000-02-29 Easterling; W. Jerry Composition and method for treating Peyronie's disease and related connective tissue disorders
BR0001144B1 (pt) * 2000-02-21 2013-10-22 Composicão farmacêutica de diclofenaco à base de vitamina-e, papaína e hialuronidase

Also Published As

Publication number Publication date
BR0006719A (pt) 2001-09-25
WO2001082956A1 (en) 2001-11-08
AU5453701A (en) 2001-11-12
EP1284750A1 (de) 2003-02-26
US20030161821A1 (en) 2003-08-28
ES2280363T3 (es) 2007-09-16
DE60126271D1 (de) 2007-03-15
MXPA02010805A (es) 2004-09-06
EP1284750B1 (de) 2007-01-24
DE60126271T2 (de) 2007-06-28
PT1284750E (pt) 2007-04-30
CA2407824A1 (en) 2001-11-08

Similar Documents

Publication Publication Date Title
US8784852B2 (en) Topical skin care composition
KR101420599B1 (ko) 항여드름제를 함유하는 조성물 및 이의 용도
AR025071A1 (es) Aditivo para mejorar la resistencia al agua de formulaciones cosmeticas o dermatologicas
ES2420516T3 (es) Composiciones tópicas y uso de las mismas para el tratamiento de afecciones relacionadas con el epitelio
EP2691077B1 (de) Topische formulierung enthaltend salicylsäure
IL154888A (en) Aqueous Pharmaceutical Gel Preparation Containing At least One Vitamin D or One Vitamin D Analog At least One Corticosteroid
ES2121461T3 (es) Utilizacion de un antagonista de cgrp para tratar el eritema cutaneo de origen neurogenico y composicion asi obtenida.
BR0109150A (pt) Método para administração de um anestésico local a um indivìduo em necessidade de um efeito anestésico local, emplastro, composição, e, recipiente
BRPI0519647A2 (pt) métodos para tratar um paciente mamìfero tendo inflamação de tecido oral, e para reduzir a inflamação do tecido oral em um paciente mamìfero
WO2002019981A3 (en) Cosmetic and pharmaceutical composition comprising chelating/sequestering agents and their cosmetic and dermatological use
WO2002009637A3 (en) Pharmaceutical compositions for the treatment of mucositis, stomatitis and behcet's syndrome
MX9501848A (es) Nuevos compuestos polienicos, composiciones farmaceuticas y cosmeticas que los contienen y sus usos.
BR9913589A (pt) Composição, e, processo cosmético para reduzir ardência ou irritação induzidas pela aplicação tópica de uma composição
ATE352313T1 (de) Pharmazeutische zusammensetzung
CA2265993A1 (en) Novel antimicrobial cosmetic compositions
JP2002226386A (ja) 植物抽出物を含有する外皮用組成物
EP0923937A3 (de) Eine kräuter formulierung verwendbar als therapeutische und kosmetische verwendung für die behandlung von allgemeinen hauterkrankungen
ES2127613T3 (es) Utilizacion de un antagonista de tnf-alfa para el tratamiento de rojeces cutaneas de origen neurogeno.
US4404198A (en) Phenyl Salicylate as a topical anti-inflammatory
BR9708297A (pt) Compostos composição farmacéutica cosmposição e uso de uma composição cosmética
JP2003252719A (ja) アロエベラゲルを主成分とした化粧品
NZ516765A (en) Topical formulations comprising skin penetration agents and the use thereof
BR9815708B1 (pt) composição tópica para tratar lesões cutáneas.
JP6903411B2 (ja) 外用組成物
WO2001022917A8 (en) Effervescent compositions comprising nimesulide

Legal Events

Date Code Title Description
RER Ceased as to paragraph 5 lit. 3 law introducing patent treaties